CARE: Combination of Acetylcysteine and Acebrophylline in Moderate to Severe Asthma and COPD Patients
The combination of N-acetylcysteine and acebrophylline improves QoL in moderate to severe COPD patients and FEV1 in both COPD and asthma patients with a favorable safety and tolerability profile. The combination appears safe and effective for managing obstructive airway disease.
Authors
- Mehebubar Rahaman
- Raja Dhar (ORCID: https://orcid.org/0000-0002-6742-5674)
- Anita Chawla (ORCID: https://orcid.org/0000-0003-2494-1094)
- Gaurav Chaudhary (ORCID: https://orcid.org/0000-0003-2167-7443)
- Rakesh K. Chawla (ORCID: https://orcid.org/0000-0003-0771-9010)
- Ashutosh Gautam
- Rajat Singal
Institutions
- Mankind Pharma (India) (IN)
Publication Details
- Journal
- Journal of Asthma and Allergy
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/jaa.s513358
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00